Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
TONAPOFYLLINE
ID: ALA414157
Max Phase: Phase
Molecular Formula: C22H32N4O4
Molecular Weight: 416.52
Molecule Type: Small molecule
Associated Items:
ID: ALA414157
Max Phase: Phase
Molecular Formula: C22H32N4O4
Molecular Weight: 416.52
Molecule Type: Small molecule
Associated Items:
Synonyms (3): Tonapofylline | BG-9928 | BG9928
Synonyms from Alternative Forms(3):
Canonical SMILES: CCCn1c(=O)c2[nH]c(C34CCC(CCC(=O)O)(CC3)CC4)nc2n(CCC)c1=O
Standard InChI: InChI=1S/C22H32N4O4/c1-3-13-25-17-16(18(29)26(14-4-2)20(25)30)23-19(24-17)22-10-7-21(8-11-22,9-12-22)6-5-15(27)28/h3-14H2,1-2H3,(H,23,24)(H,27,28)
Standard InChI Key: ZWTVVWUOTJRXKM-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: Yes | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 416.52 | Molecular Weight (Monoisotopic): 416.2424 | AlogP: 3.16 | #Rotatable Bonds: 8 |
Polar Surface Area: 109.98 | Molecular Species: ACID | HBA: 6 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 4.13 | CX Basic pKa: | CX LogP: 3.47 | CX LogD: 0.29 |
Aromatic Rings: 2 | Heavy Atoms: 30 | QED Weighted: 0.69 | Np Likeness Score: -0.11 |
1. Vu CB, Kiesman WF, Conlon PR, Lin KC, Tam M, Petter RC, Smits G, Lutterodt F, Jin X, Chen L, Zhang J.. (2006) Tricyclic imidazoline derivatives as potent and selective adenosine A1 receptor antagonists., 49 (24): [PMID:17125265] [10.1021/jm060539t] |
2. Scheiff AB, Yerande SG, El-Tayeb A, Li W, Inamdar GS, Vasu KK, Sudarsanam V, Müller CE.. (2010) 2-Amino-5-benzoyl-4-phenylthiazoles: Development of potent and selective adenosine A1 receptor antagonists., 18 (6): [PMID:20188574] [10.1016/j.bmc.2010.01.072] |
3. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, |
4. Unpublished dataset, |
Source(3):